Angiotensin II induces hypertrophic growth in neonatal cardiac myocytes, an effect that is mediated at least in part through the AT1 receptor.
Answers are grounded in this paper and cite their sources.
AT1 blockade prevents ANG II-driven hypertrophy in neonatal rat myocytes; supports mechanistic role but leaves open clinical translation.
Primary cultures of neonatal cardiac myocytes were used to determine the identity of second messengers that are involved in angiotensin II (ANG II) receptor-mediated effects on cardiac hypertrophy and the type of ANG II receptor that is involved in ANG II-induced cell growth. Treatment of myocytes with ANG II significantly increased the protein-to-DNA and the RNA-to-DNA ratios. ANG II accelerated rates of protein synthesis by 24.9%. Intracellular free calcium was transiently increased after ANG II exposure. The activity of protein kinase C in particulate fractions was transiently increased after exposure to ANG II but returned to control level. The activity of protein kinase C in the cytosol was significantly decreased at all times after exposure to ANG II. After ANG II treatment, the content of c-Fos mRNA was increased. The stimulatory effects of ANG II on these parameters were inhibited by the type 1 angiotensin II receptor (AT1) antagonist, losartan. These studies demonstrate that ANG II-induced hypertrophic growth is, at least in part, mediated through AT1 receptors.
No takes yet. Share an insight, caveat, or question.
Miyata et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: